Pharmafile Logo

FDA Map

FDAMAP is a group of global healthcare experts that conducts highly informative conferences, workshops and other training sessions for pharma, diagnostics and medical device industry professionals. Our panels of speakers include experts in clinical trials, data management, statistics, regulatory affairs, safety reporting, pharmacovigilance, social media marketing of medical products (drugs, biologics and medical devices), project management, GMP, GCP GLP, FDA/EMA audits, and information technology. Learn more about our Training and Consultancy Programs (Regulatory Workshops, FDA Seminars and Conferences, and Regulatory Consultancy) on our website www.fdamap.com

We work with professionals, regulators, and government agencies to build unique platforms for consultation, training, networking, and professional development. We strive hard to make high quality, mutually beneficial relationships with our customers and partners alike.

The FDAMap initiative is the newest venture of a group of leading experts from the industry and government to bring professionals at all levels together to create best practices based on logic, logistics, legal, and least-burdensome compliance. Visit: www.fdamap.com

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Company Details

20203 Goshen Rd,, Suite 261 Gaithersburg, Gaithersburg, Maryland, MD 20879, United States
+1-410-501-5777

 Latest Content from PMHub 

Mtech Access are exhibiting at ISPOR in the US

Press Releases | March 21, 2024 | Petauri Evidence

After many years attending ISPOR Europe, Mtech Access are excited to be attending the Global ISPOR conference May 5-8. Mtech Access are inviting ISPOR delegates to come by stand 125...

Latest European developments and new talent at Research Partnership

Press Releases | March 19, 2024 | Inizio

Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...

In-person, hybrid, or digital? State of Pharma meetings and events in 2024

We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.

King’s College London and 11 London collaborate on health psychology

Press Releases | March 17, 2024 | 11 London

We’re delighted to announce that we are working in partnership with the Health Psychology department at King's College London. Professor Rona Moss-Morris is working with the agency on a shared...

New syndicated report – Living with Ulcerative Colitis 2024

Press Releases | March 14, 2024 | Inizio

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...

Navigating Regulatory Challenges – Top 10 Most Important Advisor Questions

This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences...

Transforming San Diego for AAD 2024

The 2024 meeting of the American Academy of Dermatology has wrapped up, and Medscape has returned from a series of successful days at their booth, symposia, and offsite event. To...

Ensuring a seamless transition from design to development: Strategies for successful collaboration

Press Releases | March 12, 2024 | Graphite Digital

When designing digital products and services, the process of transitioning from design to development plays a critical role in bringing concepts to life. Our Design Lead, Edward Hart, explains why...

Market access and reimbursement in Canada – changes at CADTH

Press Releases | March 12, 2024 | Petauri Evidence

What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health...